VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMPX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMPXAmprius Technologies, Inc.
$8.72$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMPXBalance Sheet

Amprius Technologies, Inc. (AMPX) Balance Sheet

6Y historyFree accessUpdated daily

The balance sheet has deleveraged sharply, with debt-to-equity falling to 0.05 from 0.60 in 2024Q1, and cash increased to $74.5M, though retained earnings remain deeply negative at -$226.6M.

Income StatementBalance SheetCash FlowRatios

AMPX Balance Sheet

Annual statement

AMPX Balance Sheet

Amprius Technologies, Inc. (AMPX) balance sheet — 6-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20
Total Current Assets131.58M126.44M68.76M50.52M75.17M14.18M1.19M
Cash & Short-Term Investments74.52M90.47M55.16M45.76M69.7M11.49M2K
Cash Only74.52M90.47M55.16M45.76M69.7M11.49M2K
Short-Term Investments0000000
Accounts Receivable40.65M23.74M5.58M1.26M686K262K348K
Days Sales Outstanding101.56118.6784.2852.5256.7934.527.15
Inventory11.51M6.74M6.57M730K500K500K517K
Days Inventory Outstanding33.4937.9756.4611.2318.5325.728.19
Other Current Assets4.91M5.5M1.45M2.77M1.9M1.77M238K
Total Non-Current Assets17.6M30.45M52.36M57.21M8M4.35M5.47M
Property, Plant & Equipment17.54M29.2M50.99M56.91M6.99M4.21M5.25M
Fixed Asset Turnover3.90x2.50x0.47x0.15x0.63x0.66x0.89x
Goodwill0000000
Intangible Assets0000000
Long-Term Investments001.3M0000
Other Non-Current Assets63K1.26M69K305K1.01M141K217K
Total Assets149.18M156.89M121.13M107.74M83.17M18.53M6.66M
Asset Turnover0.74x0.47x0.20x0.08x0.05x0.15x0.70x
Asset Growth %111.32%29.53%12.43%29.54%348.92%178.22%-
Total Current Liabilities18.35M17.87M17.21M13.46M6.92M4.17M3.94M
Accounts Payable9.76M6.7M7.42M3.34M1.03M359K2.28M
Days Payables Outstanding35.6637.7763.7651.3938.118.45124.36
Short-Term Debt000000743K
Deferred Revenue (Current)9.45M2.84M1.64M3.43M2.66M2.36M116K
Other Current Liabilities03.41M3.63M3.44M674K217K385K
Current Ratio7.17x7.08x4.00x3.75x10.87x3.40x0.30x
Quick Ratio6.54x6.70x3.61x3.70x10.80x3.28x0.17x
Cash Conversion Cycle99.39118.8676.9812.3637.2241.75-69.02
Total Non-Current Liabilities5.2M35.21M34.44M34.48M3.22M501K1.54M
Long-Term Debt0000000
Capital Lease Obligations80.28M35.21M34.44M34.48M2.5M00
Deferred Tax Liabilities0000000
Other Non-Current Liabilities0000000
Total Liabilities23.55M53.08M51.65M47.94M10.14M4.67M5.49M
Total Debt6.38M39.87M37.76M35.57M3.02M0743K
Net Debt-68.14M-50.59M-17.4M-10.19M-66.67M-11.49M741K
Debt / Equity0.05x0.38x0.54x0.59x0.04x-0.64x
Debt / EBITDA-0.43x------
Net Debt / EBITDA4.63x------
Interest Coverage------618.50x-1482.60x
Total Equity125.64M103.81M69.47M59.8M73.03M13.86M1.17M
Equity Growth %253.04%49.43%16.17%-18.12%427.01%1085.46%-
Book Value per Share0.880.830.680.690.860.140.01
Total Shareholders' Equity125.64M103.81M69.47M59.8M73.03M13.86M1.17M
Common Stock14K13K12K9K8K7K1K
Retained Earnings-226.56M-218.36M-174.33M-129.66M-92.89M-75.4M-65.5M
Treasury Stock0000000
Accumulated OCI23K4K00000
Minority Interest0000000

Key Metrics

Growth RegimeAccelerating
ProfitabilityWeak
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

Lumpy aerospace order concentration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strengthens Amid Losses

Total assets rose to $149.2M in 2026Q2 from $104.7M in 2024Q1, while equity expanded to $125.6M, according to the latest balance sheet, despite cumulative retained losses of -$226.6M.

The balance sheet is strengthening in absolute terms, driven by equity raises that have outpaced operating losses. However, the retained earnings deficit continues to widen, indicating that the company is still in a pre-profitability phase. The increase in assets is largely funded by equity infusions rather than organic earnings, suggesting reliance on external capital.

Leverage Drops Sharply Post-Refinancing

Debt-to-equity fell from 0.60 in 2024Q1 to 0.05 in 2026Q2, with total debt reduced to $6.4M from $36.1M, as per the balance sheet, indicating a significant deleveraging event.

The dramatic reduction in debt suggests a refinancing or conversion of debt into equity, possibly improving financial flexibility. With minimal debt, the company faces low refinancing risk, but the reliance on equity funding implies dilution risk for shareholders. The low leverage provides a cushion, but the company's capital structure is now heavily equity-dependent.

Asset Mix Shifts to Cash and Inventory

Cash and equivalents increased to $74.5M in 2026Q2 from $39.0M in 2024Q1, while net PPE declined to $17.5M from $57.6M, based on reported figures, signaling a shift from fixed assets to liquid assets.

The decline in net PPE suggests either asset sales or impairments, possibly related to the scaling down of certain facilities. The increase in cash and current assets indicates a more liquid balance sheet, but the reduction in PPE may limit production capacity. The absence of goodwill is positive, reducing intangible asset risk, but the asset base is becoming more working-capital intensive.

Equity Quality Relies on External Infusions

Equity grew to $125.6M in 2026Q2 from $59.9M in 2024Q1, but retained earnings remain deeply negative at -$226.6M, as per the balance sheet, indicating that equity is primarily from capital raises.

The equity base is of lower quality because it is built on contributed capital rather than retained earnings. The persistent negative retained earnings highlight ongoing losses, and the reliance on equity raises suggests potential dilution. Stock-based compensation, averaging $2.0M per quarter, further dilutes existing shareholders without adding cash.

Liquidity Buffer Ample but Burn Persists

Current ratio improved to 7.17 in 2026Q2 from 4.67 in 2024Q1, with cash of $74.5M, according to the balance sheet, providing a strong buffer against near-term obligations.

The high current ratio indicates ample liquidity to cover short-term liabilities, but the company continues to burn cash, with operating cash flow negative in all quarters. The cash position of $74.5M, combined with the low debt, suggests a runway of several quarters, but the burn rate and lumpy order timing create uncertainty. Investors should monitor whether the cash buffer is sufficient to fund operations until profitability is achieved.

Deferred Revenue Signals Order Timing Risk

Deferred revenue rose to $3.2M in 2026Q2 from $705K in 2025Q3, as per the balance sheet, suggesting increased customer prepayments, but the volatility indicates lumpy order recognition.

The increase in deferred revenue may indicate strong demand, but the fluctuation across quarters suggests that revenue recognition is tied to specific project milestones. This could lead to earnings volatility and may not represent a stable recurring revenue stream. The reliance on a few large aerospace contracts, as highlighted in prior analysis, makes the balance sheet sensitive to order timing and potential cancellations.

AMPX — Frequently Asked Questions

Quick answers to the most common questions about buying AMPX stock.

What are the total assets of Amprius Technologies, Inc. (AMPX)?

As of 2025, Amprius Technologies, Inc. (AMPX) had total assets of $156.9M including $126.4M in current assets.

How much debt does Amprius Technologies, Inc. (AMPX) have?

Amprius Technologies, Inc. (AMPX) carries total debt of $39.9M, offset by $90.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Amprius Technologies, Inc.?

Amprius Technologies, Inc. (AMPX) has total shareholders' equity (book value) of $103.8M ($0.83 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Amprius Technologies, Inc.'s current ratio and liquidity?

Amprius Technologies, Inc. (AMPX) reported a current ratio of 7.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.